TopoGEN is a research diagnostics company that provides innovative products and services for researchers working with topoisomerases and engaged in mechanism based drug discovery and development. Drug Screening Kits are available to identify topoisomerase active drugs for use in cancer chemotherapy and antibacterial applications. The company also provides assay kits for assaying both prokaryotic and eukaryotic topoisomerases (type I, II, IV, gyrase), both in vitro and in vivo. We offer Turn-Key contract service to screen for new Topo Drugs. As an Experienced Contract Research Organization, the advantages are numerous.
Additionally, we produce quality topoisomerases & related assay and drug screening kits as technology transfer platforms from our lab to yours. When you become our customer, we become your partner in research. We review your data and offer valuable input.